[DOI] [PubMed] [Google Scholar] 75.Goldfine AB, Mun EC, Devine E, Bernier R, Baz-Hecht M, Jones DB, Schneider BE, Holst JJ, Patti ME
#IFM2026AIC #IFM #functionalmedicine #SDH #socialdeterminantsofhealth To view or add a comment, sign in -
Regular follow-up visits allow your provider to monitor your progress, answer questions, and adjust your treatment if necessary
Current guidelines generally favor statins and other lipid-lowering agents over niacin for cardiovascular risk reduction, making the clinical necessity of niacin an important consideration
These antiinflammatory and antiatherogenic effects of GLP-1 RAs reduce formation of atherosclerotic lesions and progression (59, 60)
In the periphery, GLP-1 agonists enhance glucose-dependent insulin secretion from pancreatic beta cells, suppress inappropriate glucagon release, and slow gastric emptying